Circulating ACE2 activity predicts mortality and disease severity in hospitalized COVID-19 patients

Objectives: Angiotensin-converting enzyme 2 (ACE2) represents the primary receptor for SARS-CoV-2 to enter endothelial cells. Here we investigated circulating ACE2 activity to predict the severity and mortality of COVID-19. Methods: Serum ACE2 activity was measured in COVID-19 (110 critically ill an...

Descripció completa

Dades bibliogràfiques

Autors principals:	Miklós Fagyas, Zsolt Fejes, Renáta Sütő, Zsuzsanna Nagy, Borbála Székely, Marianna Pócsi, Gergely Ivády, Edina Bíró, Gabriella Bekő, Attila Nagy, György Kerekes, Zoltán Szentkereszty, Zoltán Papp, Attila Tóth, János Kappelmayer, Béla Nagy, Jr.
Format:	Artigo
Idioma:	Inglês
Publicat:	Elsevier 2022-02-01
Col·lecció:	International Journal of Infectious Diseases
Matèries:	SARS-CoV-2 ACE2 inflammation COVID-19 disease biomarker outcome
Accés en línia:	http://www.sciencedirect.com/science/article/pii/S1201971221008766
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!